Dr. Vicente Martí-Centelles studied chemistry at the University Jaume I, obtaining his PhD in the area of supramolecular chemistry in 2012. His PhD, funded through a FPU fellowship from the Spanish Ministry of Science and Education, focused on the design and synthesis of macrocyclic compounds for molecular recognition. During his PhD he carried out two short research stays at University Zaragoza (Spain, 2009) and Imperial College London (UK, 2010) obtaining a PhD prize from the University. After postdoctoral research in The University of Edinburgh (UK) and University of Bordeaux/CNRS (France); in 2020, he was awarded a prestigious CIDEGENT Distinguished Researcher position to develop as principal investigator at Universidad Politécnica de Valencia in the Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM). Current research interests involve supramolecular systems with tailored properties, in particular molecular cages, for biological applications focusing on cancer therapy.
Dr. Vicente Martí-Centelles studied chemistry at the University Jaume I, obtaining his PhD in the area of supramolecular chemistry in 2012. His PhD, funded through a FPU fellowship from the Spanish Ministry of Science and Education, focused on the design and synthesis of macrocyclic compounds for molecular recognition. During his PhD he carried out two short research stays at University Zaragoza (Spain, 2009) and Imperial College London (UK, 2010) obtaining a PhD prize from the University. After postdoctoral research in The University of Edinburgh (UK) and University of Bordeaux/CNRS (France); in 2020, he was awarded a prestigious CIDEGENT Distinguished Researcher position to develop as principal investigator at Universidad Politécnica de Valencia in the Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM). Current research interests involve supramolecular systems with tailored properties, in particular molecular cages, for biological applications focusing on cancer therapy.